Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 118,462 | 136,490 | 130,714 | 134,563 | 115,468 |
| Cost of Goods | 1,667 | 2,413 | 2,136 | 2,667 | 2,950 |
| Gross Profit | 116,795 | 134,077 | 128,578 | 131,896 | 112,518 |
| Operating Expenses | 171,046 | 180,553 | 159,580 | 166,214 | 226,484 |
| Operating Income | -53,584 | -46,063 | -30,866 | -33,651 | -113,016 |
| Other Income | 8,645 | 5,173 | 4,451 | 83 | 445 |
| Pre-tax Income | -44,939 | -40,890 | -26,415 | -33,568 | -112,571 |
| Income Tax | -1,918 | 835 | 768 | 443 | 485 |
| Net Income Continuous | -43,021 | -41,725 | -27,183 | -34,011 | -113,056 |
| Net Income | $-43,021 | $-41,725 | $-27,183 | $-34,011 | $-113,056 |
| EPS Basic Total Ops | -0.27 | -0.26 | -0.17 | -0.21 | -0.70 |
| EPS Basic Continuous Ops | -0.27 | -0.26 | -0.17 | -0.21 | -0.70 |
| EPS Diluted Total Ops | -0.27 | -0.26 | -0.17 | -0.21 | -0.70 |
| EPS Diluted Continuous Ops | -0.27 | -0.26 | -0.17 | -0.21 | -0.70 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.26 | -0.17 | N/A | N/A |
| EBITDA(a) | $-55,425 | $-47,668 | $-31,549 | $-33,036 | $-112,053 |